Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 2/6 |
Financial Health | 6/6 |
Dividends | 2/6 |
Societe de Promotion Pharmaceutique du Maghreb S.A. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | د.م940.00 |
52 Week High | د.م1,110.00 |
52 Week Low | د.م933.00 |
Beta | -0.15 |
1 Month Change | -6.00% |
3 Month Change | -6.00% |
1 Year Change | n/a |
3 Year Change | 11.24% |
5 Year Change | 10.59% |
Change since IPO | -3.79% |
Recent News & Updates
Recent updates
Shareholder Returns
PRO | MA Pharmaceuticals | MA Market | |
---|---|---|---|
7D | -3.1% | 1.3% | 0.07% |
1Y | n/a | 11.4% | 20.8% |
Return vs Industry: Insufficient data to determine how PRO performed against the MA Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how PRO performed against the MA Market.
Price Volatility
PRO volatility | |
---|---|
PRO Average Weekly Movement | n/a |
Pharmaceuticals Industry Average Movement | 4.7% |
Market Average Movement | 3.8% |
10% most volatile stocks in MA Market | 6.6% |
10% least volatile stocks in MA Market | 2.4% |
Stable Share Price: PRO has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine PRO's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1947 | n/a | Salameh Al Araideh | https://www.promopharm.co.ma |
Societe de Promotion Pharmaceutique du Maghreb S.A. produces, commercializes, imports, and exports medicines, derma-pharmaceuticals, and cosmetic products in Africa. It subcontracts medicines for national and international laboratories. The company was founded in 1947 and is headquartered in Had-Soualem, Morocco.
Societe de Promotion Pharmaceutique du Maghreb S.A. Fundamentals Summary
PRO fundamental statistics | |
---|---|
Market cap | د.م940.00m |
Earnings (TTM) | د.م65.72m |
Revenue (TTM) | د.م747.84m |
14.3x
P/E Ratio1.3x
P/S RatioIs PRO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
PRO income statement (TTM) | |
---|---|
Revenue | د.م747.84m |
Cost of Revenue | د.م370.90m |
Gross Profit | د.م376.94m |
Other Expenses | د.م311.22m |
Earnings | د.م65.72m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 65.72 |
Gross Margin | 50.40% |
Net Profit Margin | 8.79% |
Debt/Equity Ratio | 23.1% |
How did PRO perform over the long term?
See historical performance and comparison